STOCK TITAN

Advanced Health Intelligence Ltd. American Depositary Shares - AHI STOCK NEWS

Welcome to our dedicated page for Advanced Health Intelligence Ltd. American Depositary Shares news (Ticker: AHI), a resource for investors and traders seeking the latest updates and insights on Advanced Health Intelligence Ltd. American Depositary Shares stock.

Advanced Health Intelligence Ltd (AHI), listed on both the ASX and NASDAQ under the symbol AHI, is a pioneer in the realm of digital health. The company specializes in delivering scalable health assessments and risk stratification through proprietary technology accessible via smartphones. Their main services include biometric scans that provide vital signs and health risk estimates for individuals. AHI's technology leverages computer vision, machine learning models, and patented algorithms to offer secure and user-friendly health assessments.

AHI has developed a comprehensive suite of health assessment tools designed for healthcare providers, insurers, employers, and government agencies. These tools include:

  • Body dimension and composition assessments: Identifying obesity-related comorbidities like diabetes.
  • Blood biomarker prediction: Estimating levels of HbA1C, HDL, LDL, and projecting a 10-year mortality risk.
  • Transdermal Optical Imaging: Providing vital signs and cardiovascular disease risk estimates.
  • On-device dermatological skin identification: Capable of recognizing 588 skin conditions across 133 categories, including Melanoma.

AHI's solutions are acclaimed for their scalability and ease of use, making health assessments accessible anytime and anywhere. The company continuously enriches its offerings through strategic collaborations and partnerships worldwide, such as recent agreements in Vietnam with OneClinic and in the Middle East with Dr. Walid Abbas Zaher. Furthermore, AHI’s collaborations with insurance companies like Unisure and innovative projects like the Bearn partnership in the USA demonstrate its extensive market reach and adaptability.

The company’s innovative Biometric Health Assessment (BHA) via smartphone encapsulates several key steps:

  1. FaceScan: Determines blood pressure risk zones and gathers demographic and lifestyle data.
  2. Photoplethysmogram (PPG) Resting Heart Rate Measurement: Captures resting heart rate to evaluate baseline heart health.
  3. BodyScan: Produces waist and hip circumference and body fat percentage.
  4. Cardiovascular Fitness Evaluation: Assesses cardiovascular fitness through an exertion test and heart rate recovery monitoring.

By integrating these steps, AHI provides an immediate, comprehensive health risk assessment, making it an invaluable tool for early detection and management of chronic diseases.

In summary, Advanced Health Intelligence Ltd stands at the forefront of health-tech innovation, committed to improving global health outcomes and enhancing health literacy. Through their robust technology and strategic collaborations, AHI aims to revolutionize digital health care on a global scale.

Rhea-AI Summary
Advanced Health Intelligence (AHI) CEO Scott Montgomery will provide an update on the company's traction with its digital health solutions at the Microcap Conference in Atlantic City. The presentation will cover progress on AHI's Biometric Health Assessment academic validation, geographical focuses, and updates on imminent commercialization milestones. The company is leveraging AI in its digital solutions to provide non-invasive biometric scans from a smartphone, aiming to bring biometric health risk assessments to more individuals in 2024. AHI has also announced several international agreements and is negotiating commercial partnerships with key global health stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.81%
Tags
none
-
Rhea-AI Summary
Advanced Health Intelligence Ltd (AHI) has signed a binding term sheet with OneClinic to integrate AHI's Biometric Health Assessment capabilities into OneClinic's digital health record system. The partnership aims to conduct 5,000 health assessments in Vietnam and target 1 million paid users in the first 12 months after commercial launch. Vietnam's population of approximately 100 million and high prevalence of chronic diseases make it a promising market for innovative healthcare solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
none
-
Rhea-AI Summary
Advanced Health Intelligence celebrates recognition of Dr. Walid Abbas Zaher as one of the Top Healthcare Leaders for 2023 by Forbes Middle East
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.45%
Tags
none
Rhea-AI Summary
AHI partner Bearn LLC signs new collaboration with OnCore Innovations Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.36%
Tags
none
-
Rhea-AI Summary
Advanced Health Intelligence Ltd clarifies partnership with Bearn and retracts press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
none
-
Rhea-AI Summary
AHI partner Bearn signs commercial partnership with AIG to acquire and streamline underwriting solutions. AIG reported over $50 billion in revenue in 2022. Bearn and AIG distribution to cover over 6 million lives across the USA and Canada. Bearn plans to launch the integrated platform in November 2023. Bearn rewards users with cash for achieving better health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
none
Rhea-AI Summary
AHI signs LOI with Unisure.SCOR to develop digital underwriting solution using AHI's Biometric Health Assessment. Collaboration aims to create innovative insurance offerings. SCOR and Unisure to deploy AHI's technology to assess health risk in 5,000 individuals. AHI anticipates revenue generation upon deployment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
none
-
Rhea-AI Summary
AHI selected as a finalist in Singapore's Healthcare InnoMatch program, with a chance to win a validation project worth up to SGD $400,000. AHI's innovative biometric health assessment solution addresses Singapore's healthcare challenges. The program is supported by key healthcare organizations and has an estimated setup cost of S$1 billion. AHI's BHA is a comprehensive care model that provides real-time health insights and risk indicators, aligning with the goals of Healthcare InnoMatch. AHI looks forward to showcasing its solution at the 2023 InnoMatch Awards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
Rhea-AI Summary
AHI secures $1.5M in funding through convertible loan facility, with potential to increase to $5M. Loans can be converted to shares at A$0.30 per share. Company aims to close three funding proposals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
Rhea-AI Summary
AHI enters collaboration with Bin Farhood Group to deploy technology in MENA region.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.93%
Tags
none

FAQ

What is the market cap of Advanced Health Intelligence Ltd. American Depositary Shares (AHI)?

The market cap of Advanced Health Intelligence Ltd. American Depositary Shares (AHI) is approximately 13.1M.

What does Advanced Health Intelligence Ltd (AHI) specialize in?

AHI specializes in delivering scalable health assessments and risk stratification through proprietary technology accessible via smartphones.

What kind of health assessments does AHI offer?

AHI offers body dimension and composition assessments, blood biomarker predictions, transdermal optical imaging for vital signs, and on-device dermatological skin identification.

How does AHI’s Biometric Health Assessment (BHA) work?

AHI’s BHA involves steps like FaceScan, Photoplethysmogram (PPG) Resting Heart Rate Measurement, BodyScan, and Cardiovascular Fitness Evaluation to provide a comprehensive health risk assessment.

What are some recent strategic collaborations of AHI?

Recent strategic collaborations include agreements with OneClinic in Vietnam, partnerships for digital transformation in the Middle East, and projects with insurance companies like Unisure.

How is AHI’s technology beneficial for chronic disease management?

AHI’s technology enables early identification of health risks, facilitating timely interventions and better management of chronic diseases.

What is AHI's mission?

AHI aims to improve healthcare outcomes, enhance health literacy, and support the early detection and management of various health conditions.

What are some unique features of AHI’s health assessments?

Unique features include on-device body dimensioning, blood biomarker prediction, vital signs estimation through transdermal imaging, and skin condition identification.

Which regions is AHI currently focusing on for expanding its services?

AHI is focusing on regions like Southeast Asia, the Middle East, and the USA for expanding its digital health services.

How does AHI ensure the privacy and security of health data?

AHI uses advanced computer vision, machine learning models, and patented algorithms to ensure a private and secure way for individuals to perform health assessments.

Can individuals use AHI’s health assessments on their own?

Yes, AHI’s health assessments are designed to be user-friendly and can be conducted by individuals using their smartphones.

Advanced Health Intelligence Ltd. American Depositary Shares

Nasdaq:AHI

AHI Rankings

AHI Stock Data

13.10M
241.43M
0.06%
0.3%
Software - Application
Technology
Link
United States of America
South Perth